Updated Mar 28, 2007 at 22:47 EST.
In volume 11 of
Expert Opinion on Emerging Drugs published in March 2006, Marcel Waldinger, PhD discusses drug therapy for lifelong premature ejaculation ( PE ). Prevailing research into lifelong premature ejaculation ( PE ) considers the neurotransmitter serotonin to play a key roll in the condition. While a specific cause is unknown, there are more likely psychological and physical factors involved.
Since there are no specific drugs designed to treat premature ejaculation ( PE ), taking selective serotonin reuptake inhibitors ( SSRI ) appears to provide the greatest amount of relief. There are side effects to using approach, and the most appropriate drug could be an SSRI with a short half-life that could be taken 1-2 hours prior to sexual intercourse. Animal studies indicate that the specific serotonin antagonist (5-HT1A) may provide the basis for a new type of medication that will work best on demand.
Written by the PEhomepage.com Editorial Team.
Back to Articles 
Latest News Archive 
E-mail a Friend
